Skip to main content
Clinical Trials/IRCT2015102824754N1
IRCT2015102824754N1CompletedPhase 3

Clinical trial of the effects of misoprostol injection compared with oxytocin injection in the umbilical vein in treatment of placenta retaining after delivery

Tehran University of Medical Sciences0 sites44 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
44

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 50 years (—)
Sex
Female

Inclusion Criteria

  • During the first and second stages of labor with success, leaving the pair within half an hour after leaving the fetus from the uterus, to obtain written consent from patients to participate in the study
  • Exclusion criteria:
  • Maternal and fetal problems that lead to vaginal delivery is possible. ; Placenta within half an hour after leaving the fetus from the uterus, patient request for exclusion

Exclusion Criteria

  • Not provided

Investigators

Similar Trials

The effect of misoprostol and oxytocin in... | Clinical Trial